AIM
Axiom Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $312K | Buy |
567
+59
| +12% | +$32.5K | 0.81% | 40 |
|
|
2022
Q3 | $259K | Sell |
508
-13
| -2% | -$6.63K | 0.52% | 44 |
|
|
2022
Q2 | $282K | Sell |
521
-3
| -0.6% | -$1.62K | 0.81% | 46 |
|
|
2022
Q1 | $310K | Sell |
524
-169
| -24% | -$100K | 0.67% | 49 |
|
|
2021
Q4 | $462K | Sell |
693
-40
| -5% | -$26.7K | 0.45% | 59 |
|
|
2021
Q3 | $420K | Hold |
733
| – | – | 0.42% | 59 |
|
|
2021
Q2 | $374K | Buy |
733
+49
| +7% | +$25K | 0.29% | 81 |
|
|
2021
Q1 | $312K | Sell |
684
-9,568
| -93% | -$4.36M | 0.25% | 98 |
|
|
2020
Q4 | $319 | Buy |
10,252
+9,491
| +1,247% | +$295 | 0.29% | 84 |
|
|
2020
Q3 | $336K | Sell |
761
-57
| -7% | -$25.2K | 0.38% | 64 |
|
|
2020
Q2 | $297K | Buy |
818
+89
| +12% | +$32.3K | 0.39% | 72 |
|
|
2020
Q1 | $208K | Sell |
729
-34
| -4% | -$9.7K | 0.37% | 79 |
|
|
2019
Q4 | $247K | Sell |
763
-1,036
| -58% | -$335K | 0.35% | 87 |
|
|
2019
Q3 | $523K | Sell |
1,799
-7,823
| -81% | -$2.27M | 0.4% | 73 |
|
|
2019
Q2 | $2.83M | Sell |
9,622
-129
| -1% | -$38K | 0.51% | 47 |
|
|
2019
Q1 | $2.66M | Buy |
9,751
+53
| +0.5% | +$14.5K | 0.51% | 47 |
|
|
2018
Q4 | $2.17M | Buy |
+9,698
| New | +$2.17M | 0.46% | 55 |
|